✦ LIBER ✦

VALUE OF PSA VELOCITY FOR PREDICTING BIOPSY OUTCOME IN PREVIOUSLY SCREENED MEN PARTICIPATING IN THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC)

✍ Scribed by Lilja, Hans; Vickers, Andrew J; Cronin, Angel M; Scardino, Peter T; Aus, Gunnar; Roobol, Monique J; Hugosson, Jonas; Schroder, Fritz H

Book ID: 123198496
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 193 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61764-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term radical prostatectomy outcomes

Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam

✍ Stacy Loeb; Xiaoye Zhu; Fritz H. Schroder; Monique J. Roobol 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

133 PSA-pyramid in men with low range PS

133 PSA-pyramid in men with low range PSA: PCa incidence and mortality – a plea for risk-based prostate cancer screening strategy in the European Randomized study of Screening for Prostate Cancer (ERSPC), Aarau

✍ Randazzo, M.; Seiler, D.; Beatrice, J.; Baumgartner, M.; Huber, A.; Grobholz, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 94 KB

1934 PROSTATE SPECIFIC ANTIGEN (PSA)-PYR

1934 PROSTATE SPECIFIC ANTIGEN (PSA)-PYRAMID IN MEN WITH LOW RANGE PSA: PROSTATE CANCER INCIDENCE AND MORTALITY - A PLEA FOR RISK-BASED PROSTATE CANCER SCREENING STRATEGY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC), AARAU

✍ Randazzo, Marco; Seiler, Daniel; Beatrice, Josef; Baumgartner, Martin; Huber, An 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 118 KB

965 NO EXCESS MORTALITY AFTER PROSTATE B

965 NO EXCESS MORTALITY AFTER PROSTATE BIOPSY: RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

✍ S.C. Carlsson; E. Holmberg; A.P. Auvinen; S.M. Moss; M.J. Roobol; F.H. Schröder; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Predictors for biopsy outcome in the Eur

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)

✍ Kranse, Ries; Beemsterboer, Petra; Rietbergen, John; Habbema, Dik; Hugosson, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

In the European Randomized Study of Screening for Prostate Cancer (ER-SPC, Rotterdam region), men aged 55-74 years are screened for prostate cancer by prostatespecific antigen (PSA) sampling, digital rectal examination (DRE), and transrectal ultrasound investigation (TRUS). All men with a PSA Ն4 ng/

PSA doubling time predicts the outcome a

PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

✍ Khatami Ali; Aus Gunnar; Damber Jan-Erik; Lilja Hans; Lodding Pär; Hugosson Jona 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

## Abstract This study reports the outcome of active surveillance in men with PSA screening‐detected prostate cancer (PC), and PSA doubling time (PSADT) was evaluated as a predictor of selecting patients to active treatment or surveillance. On December 31, 1994, 10,000 men were randomized to bienni